Clonal Evolution Analysis of a Rare Acute Promyelocytic Leukemia Patient Transforming from Essential Thrombocythemia

Overview

Journal Ann Hematol

Specialty Hematology

Date 2023 Feb 7

PMID 36749404

Authors

Rong Zhang

Yabin Liu

Huan Song

Yun Tan

Wen Jin

Huiying Zhao

Xiaowu Liu

Jing Li

Gangfeng Wang

Li Chen

Yingmin Liang

Kankan Wang

Affiliations

Soon will be listed here.

Citing Articles

Transformation into acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report.

Asou C, Sakamoto T, Suzuki K, Okuda I, Osaki A, Abe R J Med Case Rep. 2024; 18(1):372.

PMID: 39154170 PMC: 11330597. DOI: 10.1186/s13256-024-04691-0.

References

Cerquozzi S, Tefferi A . Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J. 2015; 5:e366. PMC: 4670948. DOI: 10.1038/bcj.2015.95. View

Campbell P, Green A . The myeloproliferative disorders. N Engl J Med. 2006; 355(23):2452-66. DOI: 10.1056/NEJMra063728. View

Li J, Kent D, Godfrey A, Manning H, Nangalia J, Aziz A . JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease. Blood. 2014; 123(20):3139-51. DOI: 10.1182/blood-2013-06-510222. View

Barosi G, Bergamaschi G, Marchetti M, Vannucchi A, Guglielmelli P, Antonioli E . JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Blood. 2007; 110(12):4030-6. DOI: 10.1182/blood-2007-07-099184. View

Braun T, Maxson J, Agarwal A, Dunlap J, Spurgeon S, Traer E . Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome. Leuk Res Rep. 2015; 4(1):8-11. PMC: 4306096. DOI: 10.1016/j.lrr.2014.12.003. View